 "Why aren't cancer drugs better? The targets might be wrong")
Tzar Labs, a molecular diagnostic company, and Mumbai-based Epigeneres Biotechnology, have claimed a breakthrough with their RNA-marker based technology for early detection of cancer rooted in stem cell biology. The blood tests, which can help determine whether cancer is absent, imminent, or present and also detect the different stages of the disease; will be launched by the end of this year.
Ashish Tripathi, founder and CEO of Tzar Labs, said that they are awaiting the regulatory approvals, and are building the first laboratory in Mumbai now. “We want to have labs in Delhi, Mumbai, Bangalore and Hyderabad to begin with.
